Knowledge Center
Poster / Nov 12, 2017
Optimizing Disintegration in Tablets of Amorphous Solid Dispersions
Source:
AAPS 2017
Good bioavailability of amorphous solid dispersions (ASDs) not only depends on dissolution rate/extent but also on the capability to inhibit/avoid crystallization, ensuring that supersaturated state is retained to promote absorption. Here, the type and amount of carrier polymer used in ADSs preparation have a strong impact on the rate and extent of precipitation.
Related links
Also in the Knowledge Center
/ Jun 01, 2024
Amorphous solid dispersions for nasal delivery - Powder formulation and particle engineering considerations
Read more
Scientific Article
Scientific Article
/ Feb 15, 2024
Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
Read more
Scientific Article